The SemaCyte® Multiplexing Platform has been launched as an expansion to the existing SemaCyte Microcarrier platform to utilize optical barcoding to accelerate screening processes during in vitro drug discovery. The platform was designed specifically to augment microplate-based high-content imaging (HCI) approaches. The company claims the SemaCyte Multiplexing Platform uses optical barcodes to tag and differentiate individual cells and cell types while preserving natural morphology, with each microcarrier capable of carrying millions of unique identifiers. Each barcode can be viewed using brightfield microscopy, and digitally deconvoluted using the company’s Semalyse software, included within the platform.
